Advertisement
Advertisement
CRSP
CRISPR Therapeutics AG
40.56
USD+0.26
+0.65%
Jan 17, 15:58 UTC -5
Closed
...
CRISPR Therapeutics AG Profile
About
Info & Links
CEO
Samarth Kulkarni
Headquarters
ZUG, V8 CH-6300, SWITZERLAND
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
17
Employees
407
CRISPR Therapeutics AG Statistics
Valuation Measures
Market Capitalization2
3.46B
Enterprise Value
3.24B
Enterprise Value/EBITDA(ttm)
-10.34
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
16.70
Price to Book(mrq)
1.74
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-118.13%
Profit Margin(ttm)
-15453.78%
Return on Equity(ttm)
-12.15%
Return on Invested Capital(ttm)
-11.66%
Return on Assets(ttm)
-10.35%
Income Statement
Revenue(ttm)
202.83M
Revenue Per Share(ttm)
2.38
Gross Profit(ttm)
202.83M
EBITDA(ttm)3
-313.08M
Net Income Available to Common(ttm)
-239.59M
Diluted EPS(ttm)
-2.83
Share Statistics
Beta (5Y Monthly)
1.68
52-Week Change
-43.28%
S&P 500 52-Week Change
25.43%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
85.35M
Dividend Yield
0.00%
Float4
81.85M
% Held by Insiders
4.10%
% Held by Institutions
69.20%
Balance Sheet
Total Cash(mrq)
1.94B
Total Cash Per Share(mrq)
22.68
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
21.64%
Quick Ratio(mrq)
21.64%
Book Value Per Share(mrq)
22.73
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.09
Free Cash Flow(ytd)
-94.39M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement